跳至主要内容
临床试验/NCT03186547
NCT03186547Unknown早期 1 期

Satisfaction Of Adult Patients With Gummy Smile Treated By Botulinum Toxin A Injection Versus Modified Lip Repositioning Surgery : A Randomized Clinical Trial

Cairo University0 个研究点目标入组 22 人开始时间: 2017年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
入组人数
22
主要终点
Patient satisfaction and postoperative side effects

研究概览

简要总结

The aim of the proposal study is to answer the question of how to manage gummy smiles due to hypermobile upper lip with less invasive and low risk level procedure . This trial will help the practitioners and the patients in taking the convenient decision to correct the gumminess to restore lip-gingival-dental harmony and enhance smile asthetics.

详细描述

In this randomized clinical trial , two groups will be included to compare the effectiveness of a treatment modality of botulinum toxin-A injection , in the first group , on gingival display during smiling ,patient satisfaction , lower face esthetics ( upper lip length , upper lip vermillion length , interlabial gap , nasolabial angle) and the postoperative side effects . the comparator group will receive treatment by modified lip repositioning surgery ,to compare the results of the intervention group that can possibly obtained without undergoing surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

single blind

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Adults with age range from 18 - 30 years.
  • Excessive gingival display more than 3 mm during smiling.
  • Patients having hypermobile upper lip with or without (mild / moderate) vertical maxillary excess.
  • Patients with normal morphology of clinical crowns.
  • Normal lip separation (ILG) at rest
  • Medically free subjects.

排除标准

  • Patients with systemic diseases or neuromuscular disorders.
  • Gummy smile with gingival display more than 8 mm during smiling.
  • Severly long face (VME) patients.
  • Patients with periodontal disease or gingival hyperplasia .
  • Medically compromised patients contraindicated for surgery .
  • Pregnant or lactating female patients.
  • Patients with inadequate attached gingiva .

研究组 & 干预措施

Botulinum Toxin A Injection

Experimental

this group will receive Botulinum Toxin A Injection at doses of 2.5 or 5 IU (depending on the degree of gum exposure) on each side of the nasolabial fold with follow up at at 2,4,8,12 and 24 weeks.

干预措施: Botulinum Toxin A Injection (Drug)

Modified Lip Repositioning Surgery

Experimental

this group will receive Modified Lip Repositioning Surgery with follow up at at 2,4,8,12 and 24 weeks.

干预措施: Modified Lip Repositioning Surgery (Procedure)

结局指标

主要结局

Patient satisfaction and postoperative side effects

时间窗: at 4 weeks

it will be assessed using Questionnaire.

次要结局

  • Lower face esthatics: a) upper lip length b) upper lip- vermillion length c) interlabial gap(at 4,8 and 12 weeks)
  • stability of gummy smile correction.(at the end of 24 weeks.)
  • Lower face esthatics: d)nasolabial angle(at 4,8 and 12 weeks)
  • Improvement of gingival display upon smiling(at 4,8 and 12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zeinab mohamed

principal investigator

Cairo University

相似试验

Satisfaction Of Adult Patients With Gummy Smile... | 临床试验